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Dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is a type II C-type lectin that functions as an adhesion receptor and mediates binding and internalization of pathogens such as virus (human immunodeficiency virus, hepatitis C), bacteria (Mycobacterium), fungi, and parasites. DC-SIGN expression in vivo is primarily restricted to interstitial dendritic cells (DC) and certain tissue macrophages. We now report that leukemic THP-1 cells, widely used as a model for monocytemacrophage differentiation, express very low basal levels of DC-SIGN and that DC-SIGN expression in THP-1 cells is regulated during differentiation. Differentiation-inducing agents (phorbol ester
Dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN, CD209)
1 is a type II membrane protein with a C-type lectin extracellular domain (1) whose expression is restricted to interstitial dendritic cells (DCs), monocyte-derived DCs (MDDCs) (1), a small subset of CD14ϩ peripheral blood DCs (1, 2) and certain tissue macrophages (3, 4) . Structurally, DC-SIGN contains a carbohydrate-binding lectin domain, a "neck" region with seven 23-amino acid repeats, and a transmembrane region followed by a cytoplasmic tail with recycling and internalization motifs (1, 5) . DC-SIGN recognizes a large array of pathogens, including HIV (6), Ebola virus (7), Leishmania amastigotes (8) , Mycobacterium tuberculosis (9, 10) , Schistosoma mansoni, Helicobacter pylori (11) , and Candida (12) in a mannose or fucose-dependent manner (11, 13, 14) . It is currently accepted that DC-SIGN mediates HIV capture by DC in peripheral tissues and enhances the infection in trans of cells expressing HIV receptors and co-receptors (6, 15, 16) . In addition DC-SIGN mediates the establishment of the initial contact between DC and naive T lymphocytes through its recognition of ICAM-3 (1) and mediates dendritic cell trafficking through interactions with endothelial ICAM-2 (17) .
DC-SIGN expression is induced de novo during the generation of monocyte-derived dendritic cells (1) , and, consequently, it is normally considered as a DC-specific phenotypic marker. However, DC-SIGN has been also detected on synovial, placenta, and alveolar macrophages (3, 4) . Moreover, the expression of DC-SIGN is largely dependent on IL-4 (18), a cytokine whose action drives monocyte/macrophages into the "alternative activation" pathway (19) or results in the generation of monocyte-derived dendritic cells (MDDC) (if combined with GM-CSF) (20) . Given its characteristic cell-restricted expression and the relevance of its functional activities, the availability of a cell line with inducible DC-SIGN expression would * This work was supported by the Ministerio de Ciencia y Tecnología (Grant SAF2002-04615-C02-01), Fundación para la Investigación Prevención del SIDA en Españ a (FIPSE), and the Fondo de Investigaciones Sanitarias (Grant 01/0063-01) (to A. L. C.) and by the Comunidad Autónoma de Madrid (Grant 08.3/0003/2001.1) and the Fondo de Investigaciones Sanitarias (Grant 00/0221) (to E. F.-R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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facilitate the study of the molecular mechanisms that underlie DC differentiation and macrophage alternative activation pathways. In the present report we describe that myeloid THP-1 cells, widely used as a monocyte/macrophage differentiation model (21) (22) (23) (24) , display inducible expression of DC-SIGN, and acquire DC-SIGN-dependent functions when differentiated in the presence of protein kinase C activators and IL-4. The cytokines and factors that modulate DC-SIGN expression in differentiating THP-1 cells (IL-13, TNF-␣, LPS, and vitamin D 3 ) also affect DC-SIGN expression on monocytes and macrophages. These results indicate that the THP-1 cell line represents a useful cellular system for the analysis of the regulated expression and functional activities of DC-SIGN and suggest that DC-SIGN constitutes a marker for both DCs and alternatively activated macrophages.
EXPERIMENTAL PROCEDURES
Cytokines and Reagents-GM-CSF (Leucomax) was purchased from Schering-Plough (Kenilworth, NJ) and used at 1000 units/ml. IL-4 and TGF-␤ were obtained from R&D (Abingdon, UK) and used at 1000 units/ml and 10 ng/ml, respectively. LPS from Escherichia coli 055:B5, phorbol 12-myristate 13-acetate (PMA), bryostatin, and 1,25-dihydroxyvitamin D 3 were obtained from Sigma. The JAK2/3 inhibitor AG-490 and the MEK1/2 inhibitor U0126 were purchased from Calbiochem and used at 30 ng/ml (AG-490) and 2.5 M (U0126).
Cells-The acute monocytic leukemia cell line THP-1 was obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (complete medium) and maintained at 3-6 ϫ 10 5 cells/ml. THP-1 differentiation was induced by treatment with PMA (10 ng/ml), bryostatin (10 nM), GM-CSF (1000 units/ml), 1,25-dihydroxyvitamin D 3 (50 nM), or TGF-␤ (10 ng/ml), either alone or in combination with IL-4 (1000 units/ml). In differentiation experiments cells were routinely seeded at 5 ϫ 10 5 cells/ml in tissue culture dishes with no change of the culture medium after addition of the differentiation inducer(s). Unless otherwise indicated, IL-4 was added into the cells 24 h after treatment with either PMA or bryostatin, and differentiation allowed to proceed for 96 h (PMA) or 72 h (bryostatin). For subsequent analysis, differentiated THP-1 cells were detached from tissue culture plates by incubation in PBS 5 mM EDTA on ice.
Human peripheral blood mononuclear cells were isolated from buffy coats from normal donors over a Lymphoprep (Nycomed, Norway) gradient according to standard procedures. Monocytes were purified from peripheral blood mononuclear cells by a 1-h adherence step at 37°C in complete medium or by magnetic cell sorting using CD14 microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany). To generate monocyte-derived macrophages, adherent monocytes were cultured at 0.5-1 ϫ 10 6 cells/ml in complete medium containing 1000 units/ml GM-CSF for 5-7 days, with cytokine addition every second day. Where indicated, macrophages were treated with IL-4 (1000 units/ml) for 48 h to generate alternatively activated macrophages (19) . For DC differentiation, adherent monocytes were cultured in complete medium containing 1000 units/ml GM-CSF and 1000 units/ml IL-4, with cytokine addition every second day (20) . Leishmania pifanoi MHOM/VE/60Ltrod axenic amastigotes were grown at 31°C in simplified F29 medium containing 20% heat-inactivated fetal bovine serum. K562 cells stably transfected with DC-SIGN were cultured as described previously (18) .
Flow Cytometry and Antibodies-Cellular phenotypic analysis was carried out by indirect immunofluorescence. Monoclonal antibodies used for cell surface staining included BL6 (anti-CD1a, Immunotech, Marseille, France), B-T7 (anti-CD86), TS1/11 (anti-CD11a), UCH-M1 (anti-CD14, Santa Cruz Biotechnology, Santa Cruz, CA), and MR1 (anti-DC-SIGN, CD209) (18) . All incubations were done in the presence of 50 g/ml human IgG to prevent binding through the Fc portion of the antibodies. The supernatant from the myeloma P3X63 (X63) and the anti-c-myc 9E10 monoclonal antibody were always included as negative controls. Flow cytometry analysis was performed with an EPICS-XL flow cytometer (Coulter Científica, Madrid, Spain) using log amplifiers.
Western Blot-Cell lysates were obtained in 50 mM HEPES, pH 7.5, 250 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 0.5 mM dithiothreitol, 10 mM NaF, 1 mM Na 3 VO 4 , 20 mM Pefabloc, and 2 mg/ml of aprotinin, antipain, leupeptin, and pepstatin. 10 g of each lysate was subjected to SDS-PAGE under reducing conditions and transferred onto an Immobilon polyvinylidene difluoride membrane (Millipore, Bedford, MA). After blocking with 5% nonfat dry milk in 50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.1% Tween 20, protein detection was performed using the SuperSignal West Pico Chemiluminescent system (Pierce Northern Blot-After extensive washing in PBS, cells were harvested and total cellular RNA was isolated using RNeasy columns (Qiagen, Hilden, Germany) following the manufacturer's recommendations. RNA integrity was initially confirmed in formaldehyde-containing agarose gels. Denatured RNA (10 g) was size-fractionated on formaldehyde-containing 1% agarose gels in the presence of ethidium bromide. After electrophoresis, RNA was transferred overnight onto nitrocellulose membranes with 20ϫ SSC. Pre-hybridization was carried out overnight at 42°C in 50% formamide, 5ϫ SSC, 5ϫ Denhardt's, 50 mM sodium phosphate, pH 6.5, and 250 g/ml denatured salmon sperm DNA. Membranes were hybridized for 16 h at 42°C in the same solution containing 10 6 cpm/ml oligonucleotide-labeled probe. Blots were sequentially washed in 2ϫ SSC, 0.5% SDS at room temperature, in 0.3ϫ SSC, 0.5% SDS at 65°C, and exposed to x-ray film at Ϫ70°C. Detection of DC-SIGN mRNA was accomplished using the full-length cDNA as probe (1) .
Polymerase Chain Reaction-RT-PCR was performed essentially as described previously (25) . 2 g of RNA from untreated or PMA-or PMA plus IL-4-treated THP-1 cells was reverse transcribed in a total volume of 20 l of amplification buffer (50 mM Tris-HCl, pH 8.2, 5 mM MgCl 2 , 10 mM dithiothreitol, 50 mM KCl, 1 mM of each deoxynucleotide, 0.5 M random hexamers), including RNasin and avian myeloblastosis virus reverse transcriptase at 1 unit/l. The mixture was incubated at 25°C for 15 min, then at 42°C for 60 min, and finally for 30 min at 52°C, and the volume was then taken to 50 l with water. Amplification was carried out on 5 l of each cDNA synthesis reaction in 50 l of a solution containing 0.2 mM of each deoxynucleotide, 1 M of each oligonucleotide primer, and 2.5 units of TaqDNA polymerase (Applied Biosystems, Foster City, CA). Preliminary experiments indicated that DC-SIGN mRNA was optimally amplified after 35 cycles of denaturation (95°C, 45 s), annealing (62°C, 45 s), and extension (72°C, 1 min), followed by a 10-min extension step at 72°C. Oligonucleotides used for DC-SIGN mRNA amplification (CD209sense: 5Ј-GGGAATTCAGAGTGGGGTGA-CATGAGTGAC-3Ј and CD209antisense: 5Ј-CCCCAAGCTTGTGAAGT-TCTGCTACGCAGGAG-3Ј) (15) include the whole coding region of the prototypical DC-SIGN isoform A (DC-SIGN A) (1, 26) . Amplification of DC-SIGN isoforms was accomplished using the primer pairs CD209sense/CD209antisense, CD209soluble/CD209antisense, and CD209ALTCYT/CD209antisense. The oligonucleotide CD209soluble (5Ј-GATACAAGAGCTTAGCAGTGTCCA-3Ј) spans through the exon Ic/exon III junction previously described for potentially soluble transmembrane-lacking DC-SIGN isoforms. The oligonucleotide CD209A-LTCYT (5Ј-GGGAATTCTGGCCAGCCATGGCCTCAGC-3Ј) includes the alternative translation initiation site found in exon Ib, which originates the DC-SIGN B isoform. Amplification of TLR4 was accomplished using the oligonucleotides TLR4forward (5Ј-CCCGATTCC-ATTGCTTCTTGC-3Ј) and TLR4reverse (5Ј-AGAGGTGGCTTAGGCTC-TGATATGC-3Ј), which amplify a fragment of 266 bp from the corresponding mRNA. PCR-generated fragments were resolved in 1.5% agarose gels, purified, cloned, and sequenced following standard procedures.
DC-CK1 (AMAC1, CCL18) chemokine mRNA was amplified with oligonucleotides 5Ј-ACAAAGAGCTCTGCTGCCTC-3Ј (DC-CK1 sense) and 5Ј-CCCACTTCTTATGGGGTCA-3Ј (DC-CK1 antisense), which amplify a 156-bp fragment (27) . Control PCR reactions were performed using oligonucleotides 5Ј-GGCTGAGAACGGGAAGCTTGTCA-3Ј and 5Ј-CGGCCATCACGCCACAGTTTC-3Ј (1 M), which together amplify a 417-bp fragment from the mRNA of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (28) . Real-time PCR of DC-SIGN was performed by amplifying duplicate samples of target cDNA in a LightCycler (Roche Diagnostics GmbH) using a SYBR Green kit (Roche Diagnostics GmbH) and a primer set for the DC-SIGN lectin domain. PCR was performed for 35 cycles with an annealing temperature of 52°C, and double-stranded DNA was measured at 86°C after each cycle.
MDDC-induced Allogeneic T Lymphocyte Proliferation-Allogeneic T lymphocytes were obtained from peripheral blood of healthy adults using standard procedures. For T lymphocyte proliferation experiments, 1 ϫ 10 5 T cells was stimulated in a 96-well plate with 0.5 ϫ 10 differentiation treatments or left untreated. After a 5-day incubation period, [ 3 H]thymidine was added (1 Ci/well) during the last 16 h of co-culture, and thymidine incorporation was determined to evaluate the level of T cell proliferation. Inhibition experiments were performed by adding the corresponding monoclonal antibodies at 10 g/ml and determining thymidine incorporation after 3 days.
L. pifanoi Amastigotes Binding Assay-THP-1 cells differentiated in the presence of bryostatin plus IL-4 were resuspended in complete medium and aliquoted in 24-well plates. Parasites were labeled with the fluorescent dye CFSE (Molecular Probes, Leiden, The Netherlands) before adhesion to THP-1 cells. CFSE-labeled parasites were added onto the cells at a 5:1 ratio, and cells were incubated at 37°C for 1 h. For inhibition experiments, cells were washed with PBS/1 mM EDTA and preincubated for 10 min at room temperature with MR-1 anti-DC-SIGN antibody (1.2 g/ml). Afterward, cells were fixed (1% paraformaldehyde in PBS) for 1 h at room temperature, and cells with and without attached parasites were resolved by flow cytometry in two peaks of low and high fluorescence intensity, using an EPICS-CS (Coulter Científica, Madrid, Spain), as described (8) . (Fig. 1A) . IL-4 treatment of THP-1 cells promoted a weak but reproducible increase in DC-SIGN cell surface expression after 96 h (65% and 1.9 MFI), whereas GM-CSF had no effect and the combination of GM-CSF and IL-4 yielded no further increase in DC-SIGN expression (65% positive cells and 2.0 MFI) (Fig. 1A) . Like IL-4, treatment with PMA, which triggers proliferation arrest and differentiation of THP-1 into monocyte-like cells (21) , enhanced very slightly DC-SIGN expression after 96 h (68.3% positive cells and 1.9 MFI) (Fig. 1A) . However, the simultaneous addition of PMA and IL-4 dramatically enhanced DC-SIGN cell surface levels (93.7% positive cells and 6.7 MFI) (Fig. 1A) , indicating that IL-4 and PMA collaborate in enhancing DC-SIGN cell surface expression. The IL-4-mediated upregulation of DC-SIGN was also evaluated in Western blot and confocal immunostaining experiments. As shown in Fig. 1B , the 44-kDa complex corresponding to monomeric DC-SIGN greatly increased in cells treated with PMA and IL-4. In accordance with these data, DC-SIGN was barely detectable in PMA-treated THP-1 cells, whereas cells differentiated in the presence of PMA and IL-4 contained high levels of cytoplasmic and cell surface DC-SIGN (Fig. 1C) .
RESULTS

Basal and Inducible Expression of DC-SIGN in THP-
Next, IL-4 was added at different time points after PMA treatment to analyze the kinetics of the DC-SIGN up-regulation. As shown in Fig. 2, IL-4 up-regulation when added simultaneously or up to 48 h after the differentiation-inducing agent. In fact, IL-4 up-regulated DC-SIGN expression at all time points during the PMA-driven monocytic differentiation of THP-1 cells, even when present only during the last 24 h of culture (Fig. 2) . In agreement with cell surface expression data, DC-SIGN mRNA was barely detectable in THP-1 cells, was weakly increased by either IL-4 or PMA, and was greatly enhanced by the simultaneous addition of PMA and IL-4 (Fig. 3A) . Precise quantitation of the relative effects of PMA and IL-4 on DC-SIGN mRNA levels was performed using real-time PCR. DC-SIGN mRNA levels were significantly increased by PMA, and augmented more than 300-fold after a 24-h treatment with PMA and IL-4 ( Fig. 3B) , further confirming that the up-regulated expression of DC-SIGN reflects the augmented levels of DC-SIGN mRNA in PMA plus IL-4-treated THP-1 cells.
Requirements for DC-SIGN Up-regulation-The monocytic differentiation of THP-1 cells requires a proliferation arrest, which can be induced by phorbol esters, bryostatin, vitamin D 3 , or TGF-␤ (21-24). To determine whether proliferation arrest was the only requirement for DC-SIGN up-regulation by IL-4, cells were incubated with bryostatin, vitamin D 3 , or TGF-␤ and subsequently treated with IL-4. Like PMA, bryostatin had a minor influence on basal DC-SIGN expression, whereas vitamin D 3 abolished the weak basal DC-SIGN expression (Fig.  4A) . Flow cytometry and analysis of cellular DC-SIGN content by Western blot revealed that addition of IL-4 dramatically up-regulates DC-SIGN on bryostatin-treated cells (Fig. 4, A  and B) , whereas it had no effect on vitamin D 3 -or TGF-␤-treated cells (Fig. 4A and not shown) . Like in the case of PMA, similar levels of DC-SIGN expression were obtained when bryostatin and IL-4 were added simultaneously or in a sequential manner (Fig. 4A) . Moreover, IL-4 up-regulated DC-SIGN expression irrespective of the adhesion state of the differentiating THP-1 cells (Fig. 4C and not shown) . Therefore, IL-4-mediated up-regulation of DC-SIGN takes place at all time points during the differentiation of THP-1 cells exposed to protein kinase C-dependent differentiation-inducing agents and appears to be independent on cell-substrate interactions.
IL-4-treated Differentiated THP-1 Cells Exhibit DC-SIGN-dependent Adhesive and Pathogen-Recognition
Functions-To determine whether IL-4-treated differentiating THP-1 cells exhibited DC-SIGN-dependent effector functions, and given its capacity to mediate DC-T cell clustering and DC-induced proliferation of resting T cells (1), we tested its involvement in the proliferation of T lymphocytes induced by bryostatin plus IL-4-differentiated THP-1 cells. After a 3-day co-culture, DC-SIGN plus bryostatin plus IL-4-differentiated THP-1 cells induced a vigorous allogeneic T cell proliferation (Fig. 5, A and B) , which was almost completely abolished by a blocking monoclonal antibody against DC-SIGN (MR-1) (Fig. 5B) . Therefore, IL-4-up-regulated DC-SIGN on THP-1 cells participates in functionally relevant interactions with T lymphocytes. In addition, to evaluate the pathogen-binding function of DC-SIGN (29) on differentiated THP-1 cells, we measured the ability of bryostatin plus IL-4-treated cells to bind Leishmania amastigotes (8) . THP-1 cells differentiated in the presence of IL-4 exhibited higher amastigote binding than the corresponding cells differentiated in the absence of IL-4 ( Fig. 5C) , and the blocking MR-1 anti-DC-SIGN antibody reduced by 50% the percentage of cells with bound Leishmania amastigotes (Fig. 5C ). Altogether these results demonstrate that DC-SIGN on bryostatin plus IL-4-differentiated cells exhibits its normal adhesive and pathogen-recognition properties.
IL-4 Alters the Pattern of DC-SIGN Isoforms and Favors the Acquisition of DC and Alternatively Activated Macrophage Markers during THP-1 Differentiation-Numerous
DC-SIGN mRNA species have been detected in MDDC, which encode membrane-bound, potentially soluble isoforms and isoforms with an alternative cytoplasmic tail (26) . To characterize the DC-SIGN mRNA isoforms expressed upon differentiation in the presence of IL-4, RT-PCR analysis was performed on THP-1 cells treated with either PMA or PMA plus IL-4. The presence of IL-4 led to increased levels of several DC-SIGN mRNA species and induced the appearance of previously unreported isoforms (Fig. 5D) , some of which encode proteins with deletions in either the "neck region" or the lectin domain. PMA plus IL-4-induced differentiation also resulted in increased expression of potentially soluble DC-SIGN isoforms and of DC-SIGN isoforms containing the alternative N terminus encoded within exon Ib (Fig. 5D ). Cloning and expression of these new isoforms revealed that they are expressed on the cell surface and display some of the functional activities described for the prototypic DC-SIGN molecule (data not shown). By contrast, differentiation without IL-4 resulted in loss or diminished levels of most DC-SIGN mRNA species (Fig. 5D) . Therefore IL-4 up-regulates DC-SIGN mRNA and influences the pattern of alternatively spliced DC-SIGN isoforms during THP-1 differentiation.
The unique effects of IL-4 on the pattern of DC-SIGN mRNA isoforms in THP-1 cells prompted us to analyze other parameters normally associated with the IL-4-dependent alternative activation of macrophages (19) . As shown in Fig. 6A, IL-4 induced the appearance of the mRNA for the CCL18 chemokine, whose expression is found in DC and alternative activated macrophages (19, 30) . Similarly, the presence of IL-4 during THP-1 differentiation prevented the induction of CD14, whose expression on monocyte/macrophages is inhibited by IL-4 both in vivo (31) and in vitro (32, 33) and increased the expression of CD86 (Fig. 6B) . Therefore, the addition of IL-4 on differentiating THP-1 cells not only up-regulates DC-SIGN expression but also results in the acquisition of phenotypic and functional parameters that characterize immature DC and alternatively activated macrophages. Fig. 7B) . On the other hand, inhibition of ERK activity by U0126 reduced the up-regulation of DC-SIGN (74.5% and 2.1 MFI versus 91.8% and 4 MFI), whereas the JAK2/JAK3 inhibitor AG-490 completely prevented the cell surface up-regulation of DC-SIGN in response to IL-4 (34.6% and 0.9 MFI) (Fig. 7A) . Because inhibition of JAK activation abolished the DC-SIGNinducible expression and IL-4 triggers STAT6 activation through JAK1/3, STAT6 activation was determined in both untreated and bryostatin-treated cells. In both cases IL-4 induced STAT6 phosphorylation (Fig. 7C) , suggesting that differences in the IL-4-dependent DC-SIGN expression between THP-1 and bryostatin-treated THP-1 cells are not explained in terms of differential STAT6 activation. Conversely, IL-4 triggered STAT5 and ERK phosphorylation in THP-1 cells, whereas no STAT5 or ERK activation was detected in bryostatin-treated cells in response to IL-4 (Fig. 7C) . Therefore, untreated and bryostatin-treated THP-1 cells vary in their signaling responses to IL-4, and the differential signaling (Fig. 9A) . Similarly, TNF-␣ or LPS 2 ) were differentiated with bryostatin and IL-4, irradiated, and used to stimulate 1 ϫ 10 5 allogeneic peripheral blood T lymphocytes in 96-well plates in the absence (Ϫ) or in the presence of monoclonal antibodies against the indicated cell surface molecules. After a 3-day co-culture, [ 3 H]thymidine was added to the culture for 16 h, and T cell proliferation determined by measuring thymidine incorporation. C, binding of L. pifanoi amastigotes. THP-1 cells differentiated in the presence of bryostatin and IL-4 were incubated with CFSE-labeled amastigotes at a 1:5 ratio at 37°C for 1 h, either in the presence or in the absence of an anti-DC-SIGN antibody or human polyclonal IgG. Cells were then fixed, and the percentage of cells with bound amastigotes determined by flow cytometry as described (8) . D, identification of DC-SIGN isoforms in differentiated THP-1 cells. RNA was isolated from untreated, PMA-, and PMA plus IL-4-differentiated THP-1 cells and reverse-transcribed, and the resulting cDNA was subjected to PCR with DC-SIGN-based oligonucleotides, which specifically amplify type A isoforms (upper panel), isoforms without the transmembrane region (middle panel), or type B isoforms (lower panel). Major resulting fragments were gel-purified, cloned, and sequenced, and their corresponding structure is illustrated. inhibited the induction of DC-SIGN triggered by IL-4 (Fig. 9A) . Therefore, the effects of IL-13, vitamin D 3 , LPS, and TNF-␣ indicate that the expression of DC-SIGN is similarly regulated in peripheral blood monocytes and differentiated THP-1 cells.
Finally, we sought to evaluate whether DC-SIGN induction in IL-4-treated differentiating THP-1 cells could be reproduced in human macrophages. To that end, in vitro generated monocyte-derived macrophages were treated with IL-4 (alternatively activated macrophages), and DC-SIGN expression was analyzed by Western blot. Both IL-4 and IL-13 induced the expression of DC-SIGN in monocyte-derived macrophage, exhibiting an electrophoretic pattern of DC-SIGN identical to that observed in THP-1 cells (Fig. 9B) . Like in the case of differentiating THP-1 cells, TNF-␣, LPS, and vitamin D 3 inhibited the acquisition of DC-SIGN in alternatively activated macrophages (Fig. 9B) . Moreover, the addition of the MEK inhibitor U0126 almost completely prevented the induction of DC-SIGN in response to IL-4 (Fig. 9B) , thus resembling its inhibitory effect on differentiating THP-1 cells. Altogether, these results indicate that similar signaling pathways control the DC-SIGN-inducible expression in differentiating THP-1 cells, monocyte-derived dendritic cells and "alternatively activated" macrophages, implying that THP-1 cells represent a useful cellular model for the analysis of the molecular requirements for the DC-SIGN-regulated expression. DISCUSSION DC-SIGN was originally identified as a phenotypic marker acquired during monocyte-derived dendritic cell differentiation and endows DC with important adhesive and pathogen-recognition functions (6, 34) . The present report describes the ability of the THP-1 cell line, widely used as a monocyte/macrophage differentiation model, to up-regulate DC-SIGN expression in response to differentiation inducers and IL-4 and demonstrates that DC-SIGN expression confers THP-1 cells with pathogenrecognition and potent T cell stimulatory capabilities. The upregulated expression of DC-SIGN in THP-1 cells is dependent on signaling pathways that also control DC-SIGN expression in monocytes, macrophages, and monocyte-derived dendritic cells. Our results suggest that DC-SIGN constitutes a marker for monocyte-derived dendritic cells and alternatively activated macrophages, rather than a lineage-specific marker, and indicate that THP-1 cells represent a useful cellular system for the analysis of the molecular mechanisms that underlie the DC-SIGN-regulated expression in myeloid cells.
It is generally assumed that IL-4 prevents monocyte differentiation into macrophages, favoring DC progeny at the expense of monocytic development (35, 36) . Besides, IL-4 promotes macrophage activation along an "alternative pathway" distinct from the classic activation triggered by interferon-␥ or LPS (19) . Our results (Ref. 18 and this report) and those of others (3, 4, 37) indicate that IL-4 induces DC-SIGN expression on monocytes and monocyte-derived macrophages and is the key cytokine for DC-SIGN acquisition during monocyte-derived dendritic cell differentiation (18) . The differential expression of DC-SIGN in differentiated THP-1 in the absence (DC-SIGN dull ) or presence of IL-4 (DC-SIGN high ) further illustrates the impact of IL-4 on myeloid cell differentiation and demonstrates the IL-4 dependence of the DC-SIGN expression in both normal and transformed myeloid cells. That the expression of DC-SIGN is similarly regulated in monocytes, macrophages, and differentiated THP-1 is further illustrated by the ability of IL-13 to induce DC-SIGN expression in the three cell types. Moreover, the agents that inhibit or prevent the acquisition of DC-SIGN in differentiated THP-1 cells (LPS, TNF-␣, and vitamin D 3 ) also regulate DC-SIGN expression in normal human monocytes and macrophages in a negative fashion. Altogether, these data indicate that the signaling mechanisms regulating DC-SIGN expression in monocyte-derived macrophages and dendritic cells also control the expression of this pathogen receptor in differentiated THP-1 cells, implying that the latter can be used as a cellular model system to determine the signals and factors required for the acquisition of DC-SIGN in myeloid cells.
The IL-4-initiated signaling pathways that drive DC-SIGN expression in normal and transformed cells still remain unclear. Although numerous genes have been recently identified in T lymphocytes whose expression is induced by IL-4 in an STAT6-independent manner (38) , the ability of the JAK 2/3 inhibitor tyrphostin AG-490 to prevent DC-SIGN up-regulation on monocytes (18) and differentiated THP-1 cells (this report) suggests that STAT6 activation participates in the process. In any event, for DC-SIGN up-regulation to take place, IL-4-initiated STAT6 activation is not sufficient, because IL-4 treatment of proliferating THP-1 cells leads to STAT6 activation but not to DC-SIGN up-regulation, thus suggesting the involvement of additional pathways in the IL-4-dependent DC-SIGN up-regulation in THP-1 cells. One potential candidate is the ERK MAPK, which is differentially activated by IL-4 in proliferating and differentiated THP-1 cells and whose sustained activation has already been shown to elicit IL-4 unresponsiveness in T lymphocytes (39) .
Another interesting aspect of the DC-SIGN up-regulation in THP-1 cells is the change in the pattern of isoform expression in response to IL-4. Like other members of the C-type lectin superfamily, numerous DC-SIGN mRNA species have been identified in MDDC that would encode molecules lacking a transmembrane domain or containing shortened or alternative "neck" and cytoplasmic domains (26) . Although the subcellular location and recognition properties of these potential isoforms remain unknown, it is tempting to speculate that they might exhibit altered recognition and/or signaling capabilities, thus modulating the functionality of the prototypical membranebound DC-SIGN molecules. The pattern of DC-SIGN isoform expression in dendritic cells exhibits inter-individual variations (26), 2 and our results indicate that the presence of IL-4 not only induces but also influences the profile of DC-SIGN isoform expression. Along this line, Western blot experiments to detect DC-SIGN in differentiated THP-1 cells revealed the presence of, at least, three discrete bands in the 40-to 45-kDa range ( Figs. 1 and 4 ). Whether these bands represent differential glycosylation of a single DC-SIGN isoform or are derived from alternatively spliced mRNA is currently under investigation. The availability of the THP-1 cell line should allow the establishment of correlations between IL-4-initiated signaling routes, the appearance of individual DC-SIGN mRNA isoforms, and their exact contribution to the DC-SIGN-dependent effector functions displayed by dendritic cells and "alternatively activated" IL-4-treated macrophages.
Finally, the presence of low levels of DC-SIGN in proliferating untreated THP-1 cells, which does not correlate with any cell cycle phase (data not shown), suggests that THP-1 cells represent a myeloid differentiation stage different from other myeloid cell lines where DC-SIGN cannot be induced. In this regard, the myeloid cell line KG-1 has been reported to acquire a dendritic cell phenotype in the presence of phorbol ester and has been proposed to represent a model of human DC differentiation from CD34ϩ progenitor cells (40, 41) . However, none of these studies evaluated the expression of DC-SIGN, thus precluding comparison with our results. In the case of differentiated THP-1 cells, and in addition to DC-SIGN, other phenotypic properties of both myeloid DC and alternatively activated macrophages are also up-regulated in response to IL-4, including the expression of the DC-CK1 chemokine and the downregulation of CD14. Therefore, IL-4-treated differentiated THP-1 cells exhibit phenotypic changes that resemble those that take place during macrophage alternative activation and MDDC differentiation and, consequently, represent a useful tool to dissect the molecular basis for the DC-SIGN-restricted and -regulated expression in both cell types and to analyze the intracellular signaling events initiated upon DC-SIGN engagement by adhesion molecules and pathogens.
